TL;DR
This study identifies 50 genes (45 mRNAs, 5 miRNAs) that play a role in both postmenopausal osteoporosis (OP) and cardiovascular disease (CVD), suggesting a shared genetic basis for these common age-related conditions. By analyzing bone biopsies and integrating genomic data, the research uncovers novel molecular links that could pave the way for better understanding and potentially treating these intertwined diseases.
What Problem Does This Paper Address?
Postmenopausal osteoporosis (OP) and cardiovascular disease (CVD) are two of the most prevalent chronic conditions affecting the elderly, and epidemiological evidence strongly suggests they often occur together. Women with OP, for instance, have a significantly higher risk of experiencing acute CVD events. Despite this known comorbidity, the underlying genetic mechanisms and specific genes that contribute to both conditions have remained largely unidentified. This knowledge gap hinders our ability to fully understand the shared pathophysiology and develop integrated therapeutic strategies. This paper aims to bridge this gap by identifying shared genes and pathways involved in the pathogenesis of both OP and CVD.
Methods
The researchers employed a multi-pronged approach:
- Transcriptome Analysis: They analyzed the global gene expression profiles (using microarrays and RNA sequencing) from trans-iliac bone biopsies of 84 postmenopausal women.
- Correlation Analysis: They identified the top 1000 transcripts most strongly correlated with areal bone mineral density (aBMD).
- Bioinformatics and Pathway Analysis: These top 1000 transcripts were then analyzed using Ingenuity Pathway Analysis (IPA) and DAVID to identify genes with known or putative roles in CVD mechanisms.
- Functional Validation: The identified genes were further characterized by examining their expression in microvascular endothelial cells and cardiomyocytes, and by checking for differential expression between healthy and osteoporotic women.
- Genomic Overlap Analysis: A genetic pleiotropy-informed conditional False Discovery Rate (condFDR) method was used to identify overlaps in single nucleotide polymorphisms (SNPs) within genes associated with both BMD and CVD.
Datasets
- Bone Biopsies: Transcriptome data from 84 trans-iliac bone biopsies of postmenopausal women (aged 50-86) were used. These women were clinically characterized and did not have clinical CVD.
- Primary Endothelial Cells and Cardiomyocytes: Expression data from human dermal microvascular endothelial cells and iCell cardiomyocytes were utilized to assess the presence of shared transcripts in relevant cardiovascular tissues.
- Publicly Available GWAS Data: Data from the Musculoskeletal Knowledge Portal (MSK-KP) and other relevant databases were used to support the identification of genetic overlap.
Key Insights and Ideas
- Shared Genetic Architecture: The most striking insight is the identification of a significant overlap in genes that influence both bone mineral density and cardiovascular health. This provides strong evidence for a shared genetic basis underlying the comorbidity of OP and CVD.
- Pleiotropic Genes: The study highlights the existence of "pleiotropic" genes – genes that have multiple effects on different biological processes. These genes are not only involved in bone metabolism but also in key CVD mechanisms like inflammation, oxidative stress, and endothelial function.
- Novel Roles in OP Pathogenesis: Many of the identified genes associated with CVD risk had not previously been recognized for their role in osteoporosis pathogenesis. This opens up new avenues for research into the molecular mechanisms of OP.
- Validation Across Tissues: The finding that these shared transcripts are also expressed in endothelial cells and cardiomyocytes strengthens their relevance to CVD.
Key Results
- Fifty Shared Transcripts Identified: The study identified 50 transcripts (45 mRNAs and 5 miRNAs) that are strongly associated with aBMD and also have established roles in CVD pathogenesis.
- Functional Categories: These 50 genes are implicated in critical CVD-related processes including inflammatory response, oxidative stress, endothelial function, fibrosis, dyslipidemia, and osteoblastogenesis/calcification.
- Differential Expression: Ten of these transcripts were found to be differentially expressed in healthy women compared to osteoporotic women with fragility fractures, further supporting their role in disease.
- Genomic Support: A genetic pleiotropy-informed analysis confirmed the overlap in SNPs within several of these shared genes, providing genomic evidence for their dual roles.
Limitations and Future Work
- Participant Number: While considered extensive for this type of study, the authors acknowledge that the number of participants (84 women) may still be considered limited.
- Sex Differences: The study focused solely on postmenopausal women. Given that males are also susceptible to CVD, and the prevalence difference is diminishing, future work could explore these shared genes in a male population.
- Bone Tissue Heterogeneity: Although the authors addressed potential impacts of bone tissue heterogeneity (e.g., cell composition), it remains a factor to consider.
- Gut Microbiome: The potential influence of the gut microbiome on bone metabolism, though not directly studied, is mentioned as a factor that could impact outcomes.
The authors suggest that these findings encourage continued work to discover improved and possibly common therapies for both chronic major disorders. The identification of novel genes involved in both OP and CVD pathogenesis provides a strong foundation for future research into their mechanistic links and potential therapeutic targets.
Summary updated